GE HealthCare Technologies Inc.

GE HealthCare Technologies designs and manufactures medical imaging systems, diagnostic devices, patient monitoring equipment, and pharmaceutical contrast agents used across diagnostic, therapeutic, and patient care settings. The company develops computed tomography scanners, magnetic resonance imaging systems, X-ray equipment, ultrasound systems, and molecular imaging platforms alongside complementary software and digital solutions that support clinical workflows and data management.

The company operates through four primary segments. Imaging encompasses molecular imaging, CT, MR, X-ray systems, and women's health products. Advanced Visualization Solutions provides ultrasound systems, image-guided therapy tools, and surgical visualization products for cardiovascular, women's health, and comprehensive care applications. Patient Care Solutions offers patient monitoring devices, diagnostic cardiology equipment, consumables, maternal infant care products, and anesthesia systems. Pharmaceutical Diagnostics supplies contrast media and radiopharmaceutical agents used in CT, MR, nuclear medicine, and angiography procedures.

GE HealthCare operates with approximately 54,000 full-time employees and maintains headquarters in Chicago, Illinois. The company serves customers across the United States, Canada, and international markets. With a market capitalization of $38.4 billion, GE HealthCare functions as an independent entity following its separation from General Electric in December 2022.